Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Adiponectin Mitigates Post-Splenectomy Cognitive Deficits in

    2026-07-02

    Adiponectin Mitigates Post-Splenectomy Cognitive Deficits in Aged Rats: Mechanistic Insights via TLR4/MyD88/NF-κB Suppression

    Study Background and Research Question

    Perioperative neurocognitive disorder (PND) poses a significant clinical challenge, particularly in elderly patients undergoing major surgery, with incidence rates of cognitive impairment reaching up to 52%. The underlying mechanisms of PND remain incompletely understood, with neuroinflammation and oxidative stress considered central contributors to its pathogenesis. Recent evidence implicates the Toll-like receptor 4 (TLR4)/MyD88/nuclear factor-kappa B (NF-κB) signaling pathway in mediating these pathological processes. Adiponectin (APN), a plasma protein secreted by adipose tissue, has shown protective effects in models of metabolic and neurodegenerative disease, but its role in PND has not been fully elucidated. The central research question addressed by this study is whether adiponectin can attenuate splenectomy-induced cognitive deficits in aged rats by modulating neuroinflammatory and oxidative stress pathways.

    Key Innovation from the Reference Study

    The innovation of this work lies in its demonstration that systemic adiponectin administration before surgical trauma can significantly improve cognitive outcomes in aged rats subjected to splenectomy. The study provides mechanistic evidence that the neuroprotective effects of adiponectin are mediated by suppression of the TLR4/MyD88/NF-κB pathway, resulting in reduced microglial activation, lower proinflammatory cytokine production, and decreased markers of oxidative damage. Importantly, pharmacological manipulation of TLR4 signaling with agonists and antagonists confirmed the centrality of this pathway in mediating both the deleterious effects of surgery and the benefits of adiponectin treatment.

    Methods and Experimental Design Insights

    The investigators employed a robust experimental design using eighteen-month-old male Sprague Dawley rats, an established model for aging-related cognitive vulnerability. Six groups were established: sham, sham + APN (10 μg/kg/day intragastrically for 20 days pre-surgery), PND (splenectomy), PND + APN, PND + TAK-242 (TLR4 antagonist, 3 mg/kg i.p.), and PND + APN + LPS (TLR4 agonist, 2 mg/kg i.p.). Cognitive function was evaluated using the Morris water maze (MWM), a gold-standard spatial learning and memory test. Molecular analyses included immunohistochemistry, immunofluorescence, western blotting, and ELISA to quantify activation of TLR4/NF-κB signaling, oxidative stress markers (MDA, SOD, caspase 3), and microglial-mediated neuroinflammation (IBA1, TNF-α, IL-1β, IL-6) in the hippocampus.

    Protocol Parameters

    • Adiponectin pretreatment: 10 μg/kg/day, intragastric administration, for 20 days prior to splenectomy for maximal neuroprotective effect.
    • Control and intervention groups: Include sham, PND, PND + APN, PND + TLR4 antagonist (TAK-242, 3 mg/kg i.p.), and combined treatments to dissect pathway involvement.
    • Cognitive assessment: Morris water maze conducted post-surgery to assess spatial learning and memory retention.
    • Biochemical endpoints: Hippocampal tissue analyzed for TLR4/MyD88/NF-κB pathway activation, oxidative stress (MDA, SOD, caspase 3), and proinflammatory cytokines (TNF-α, IL-1β, IL-6).

    Core Findings and Why They Matter

    The study found that splenectomy induced marked cognitive deficits, neuroinflammation, and oxidative damage in aged rats. Adiponectin treatment significantly improved MWM performance, indicating enhanced learning and memory. Molecular analyses revealed suppression of the TLR4/MyD88/NF-κB pathway, reduced oxidative stress markers, and lower expression of microglial activation and proinflammatory cytokines in adiponectin-treated groups. The TLR4 antagonist TAK-242 mirrored these effects, while LPS (a TLR4 agonist) abolished the benefits of adiponectin, confirming the mechanistic dependency on TLR4 signaling. These results highlight the TLR4/MyD88/NF-κB axis as a convergent point linking surgical trauma to neuroinflammatory and oxidative responses underlying PND, and position adiponectin as a promising candidate for intervention.

    Comparison with Existing Research on Peptide Regulators in Neuroinflammation

    While this study focuses on adiponectin, the findings resonate with broader research on peptide hormones involved in neurovascular and metabolic regulation. For instance, Atrial Natriuretic Peptide (ANP) is recognized for its vasodilatory, natriuretic, and anti-inflammatory effects in cardiovascular contexts. Internal resources such as "Atrial Natriuretic Peptide: Workflow Optimization in Card..." and "Atrial Natriuretic Peptide (ANP), rat: Atomic Mechanisms..." detail how high-purity rat ANP supports reproducible vascular and inflammatory assays. Although ANP and adiponectin operate via distinct receptors and pathways, their shared ability to modulate inflammation and oxidative stress highlights a translational bridge between cardiovascular and neurocognitive research domains. This cross-talk is particularly relevant for the design of future studies exploring peptide regulators of neuroinflammation and cognitive resilience.

    Limitations and Transferability

    Despite its strengths, the study is limited by its focus on an aged rat model and splenectomy as a trigger for PND. The generalizability to other surgical models or to human patients with diverse comorbidities remains to be established. Furthermore, the precise interplay between adiponectin, TLR4 signaling, and other neuroimmune pathways warrants deeper investigation, including dose-response relationships and long-term outcomes. Finally, while the molecular endpoints are compelling, translation to clinical biomarkers or therapeutic protocols will require further validation.

    Research Support Resources

    For researchers aiming to model peptide hormone effects on inflammation, oxidative stress, and cognitive function, robust, high-purity peptides are essential for reproducibility. Products such as Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009) from APExBIO offer well-characterized sequence, purity, and storage parameters suitable for cardiovascular and neuroinflammation workflows. Leveraging such reagents alongside protocol guidance from resources like "Atrial Natriuretic Peptide (ANP), Rat: Advanced Assay Guidance" can facilitate translational studies into peptide-based modulation of inflammatory and oxidative mechanisms in both cardiovascular and neurological research contexts.